Fresenius SE's restructuring and dividend reinstatement signal strong growth. Read why FSNUF stock may not be a long-term buy ...

The global generic pharmaceuticals contract manufacturing market is on an upward trajectory, with a CAGR of 6.15% from 2025 to 2033. As the industry shifts towards more cost-effective and high-quality ...

THE HSE has been urged to fast-track the provision of a haemodialysis service in Ennis to reduce the travel time for Clare ...